{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:12:08Z","timestamp":1789647128190,"version":"4.0.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU21-05-00482"],"award-info":[{"award-number":["NU21-05-00482"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-19-0189"],"award-info":[{"award-number":["APVV-19-0189"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019624","name":"Fakultn\u00ed nemocnice Hradec Kr\u00e1lov\u00e9","doi-asserted-by":"publisher","award":["00179 906"],"award-info":[{"award-number":["00179 906"]}],"id":[{"id":"10.13039\/100019624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019624","name":"Fakultn\u00ed nemocnice Hradec Kr\u00e1lov\u00e9","doi-asserted-by":"publisher","award":["SVV 260\\u202F666"],"award-info":[{"award-number":["SVV 260\\u202F666"]}],"id":[{"id":"10.13039\/100019624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["LX22NPO5103"],"award-info":[{"award-number":["LX22NPO5103"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007594","name":"Univerzita Komensk\u00e9ho v Bratislave","doi-asserted-by":"publisher","award":["CZ LM2018140"],"award-info":[{"award-number":["CZ LM2018140"]}],"id":[{"id":"10.13039\/100007594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejmech.2023.115617","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T11:12:58Z","timestamp":1688123578000},"page":"115617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Antimycobacterial pyridine carboxamides: From design to in vivo activity"],"prefix":"10.1016","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8858-1529","authenticated-orcid":false,"given":"Daria El\u017cbieta","family":"Nawrot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-5788","authenticated-orcid":false,"given":"Ghada","family":"Bouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Jan\u010fourek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kl\u00e1ra","family":"Kone\u010dn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Paterov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"B\u00e1rta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Nov\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radim","family":"Ku\u010dera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Zemanov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Forbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Kordul\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oto","family":"Pavli\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Kub\u00ed\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dole\u017eal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Zitko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115617_bib1","series-title":"WHO Consolidated Guidelines on Tuberculosis. Module 5: Management of Tuberculosis in Children and Adolescents","year":"2022"},{"issue":"4\u20135","key":"10.1016\/j.ejmech.2023.115617_bib2","first-page":"305","article-title":"Facile synthesis and pesticidal activity of substituted heterocyclic pyridine compounds","volume":"67","author":"Abdel-Raheem","year":"2022","journal-title":"Rev. Roum. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115617_bib3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1021\/ma402641p","article-title":"Antimicrobial polycarbonates: investigating the impact of nitrogen-containing heterocycles as quaternizing agents","volume":"47","author":"Ng","year":"2014","journal-title":"Macromolecules"},{"issue":"72","key":"10.1016\/j.ejmech.2023.115617_bib4","doi-asserted-by":"crossref","first-page":"44247","DOI":"10.1039\/D0RA09198G","article-title":"Prescribed drugs containing nitrogen heterocycles: an overview","volume":"10","author":"Heravi","year":"2020","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115617_bib5","doi-asserted-by":"crossref","first-page":"27P","DOI":"10.1042\/bj1170027Pa","article-title":"Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope","volume":"117","author":"Winder","year":"1970","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.ejmech.2023.115617_bib6","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.tips.2019.10.005","article-title":"Pharmacological and molecular mechanisms behind the sterilizing activity of pyrazinamide","volume":"40","author":"Gopal","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"6115","key":"10.1016\/j.ejmech.2023.115617_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1228980","article-title":"Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis","volume":"339","author":"Chakraborty","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ejmech.2023.115617_bib8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.apsb.2016.07.014","article-title":"Isoniazid metabolism and hepatotoxicity","volume":"6","author":"Wang","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115617_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1472-9792(08)70019-2","article-title":"Para-aminosalicylic acid","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"issue":"38","key":"10.1016\/j.ejmech.2023.115617_bib10","doi-asserted-by":"crossref","first-page":"19856","DOI":"10.1039\/C4RA01651C","article-title":"A catalyst-free, facile and efficient approach to cyclic esters: synthesis of 4H-benzo[d][1,3]dioxin-4-ones","volume":"4","author":"Lin","year":"2014","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115617_bib11","first-page":"285","article-title":"p-Pyridoylaminobenzoic acids and their derivatives as possible tuberculostats","volume":"51","author":"Murali","year":"1969","journal-title":"J. Indian Inst. Sci."},{"key":"10.1016\/j.ejmech.2023.115617_bib12","series-title":"Method for Altering the Lifespan of Eukaryotic Organisms","author":"Goldfarb","year":"2008"},{"key":"10.1016\/j.ejmech.2023.115617_bib13","series-title":"Substituted Nicotinamides and Analogs as Activators of Caspases and Inducers of Apoptosis and the Use Thereof","author":"Cai","year":"2002"},{"key":"10.1016\/j.ejmech.2023.115617_bib14","series-title":"Small-molecule Inhibitors of Protein Synthesis Inactivating Toxins","author":"Pang","year":"2009"},{"issue":"18","key":"10.1016\/j.ejmech.2023.115617_bib15","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1016\/j.bmcl.2006.06.057","article-title":"Pharmacophore-based virtual screening: the discovery of novel methionyl-tRNA synthetase inhibitors","volume":"16","author":"Kim","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115617_bib16","first-page":"110","article-title":"Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: an up-to-date review","author":"Bouz","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115617_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115617_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/ijmy.ijmy_33_18","article-title":"Mycobacterium tuberculosis strains H37ra and H37rv have equivalent minimum inhibitory concentrations to most antituberculosis drugs","volume":"7","author":"Heinrichs","year":"2018","journal-title":"International Journal of Mycobacteriology"},{"issue":"6","key":"10.1016\/j.ejmech.2023.115617_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5588\/ijtld.10.0481","article-title":"Characteristics of skin and soft tissue infection caused by non-tuberculous mycobacteria in Taiwan","volume":"15","author":"Hsiao","year":"2011","journal-title":"Int. J. Tubercul. Lung Dis."},{"key":"10.1016\/j.ejmech.2023.115617_bib20","article-title":"Mechanism of selectivity reveals novel antifolate drug interactions","author":"Kordus","year":"2020","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.ejmech.2023.115617_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3839\/jksabc.2009.059","article-title":"Growth inhibiting activity of quinaldic acid isolated from ephedra pachyclada against intestinal bacteria","volume":"52","author":"Lee","year":"2009","journal-title":"Journal of the Korean Society for Applied Biological Chemistry"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115617_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/QCO.0b013e3283210020","article-title":"Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community","volume":"22","author":"Shenoi","year":"2009","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115617_bib23","series-title":"Determination of Minimum Inhibitory Concentrations (MICs) of Antibacterial Agents by Broth Dilution","first-page":"1","year":"2003"},{"key":"10.1016\/j.ejmech.2023.115617_bib24","series-title":"EUCAST Definitive Document E.Def 7.3.1. 2017","article-title":"Subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST), Method for the Determination of broth dilution minimum inhibitory Concentrations of Antifungal agents for yeasts","author":"Arendrup","year":"2017"},{"key":"10.1016\/j.ejmech.2023.115617_bib25","article-title":"Subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST)","author":"Arendrup","year":"2017","journal-title":"Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal agents for Conidia Forming Moulds"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115617_bib26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s13104-017-2757-8","article-title":"Galleria mellonella (greater wax moth) larvae as a model for antibiotic susceptibility testing and acute toxicity trials","volume":"10","author":"Ignasiak","year":"2017","journal-title":"BMC Res. Notes"},{"issue":"40","key":"10.1016\/j.ejmech.2023.115617_bib27","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.A113.475798","article-title":"para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis (vol 288, pg 23447, 2013)","volume":"288","author":"Zheng","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2023.115617_bib28","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.1021\/acs.jmedchem.9b00912","article-title":"Development of 3,5-dinitrophenyl-containing 1,2,4-triazoles and their trifluoromethyl analogues as highly efficient antitubercular agents inhibiting decaprenylphosphoryl-beta-d-ribofuranose 2'-oxidase","volume":"62","author":"Karabanovich","year":"2019","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115617_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/AAC.20.3.401","article-title":"Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis","volume":"20","author":"Kilburn","year":"1981","journal-title":"Antimicrob. Agents Chemother."},{"issue":"14","key":"10.1016\/j.ejmech.2023.115617_bib30","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1128\/JB.182.14.4059-4067.2000","article-title":"Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis","volume":"182","author":"Vilch\u00e8ze","year":"2000","journal-title":"J. Bacteriol."},{"issue":"46","key":"10.1016\/j.ejmech.2023.115617_bib31","doi-asserted-by":"crossref","first-page":"38434","DOI":"10.1074\/jbc.M112.400994","article-title":"A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone","volume":"287","author":"Grzegorzewicz","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115617_bib32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chembiol.2019.02.013","article-title":"Drugging the folate pathway in Mycobacterium tuberculosis: the role of multi-targeting agents","volume":"26","author":"Hajian","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"22","key":"10.1016\/j.ejmech.2023.115617_bib34","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1021\/acs.jmedchem.5b01325","article-title":"Tacrine-trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity","volume":"58","author":"Nepovimova","year":"2015","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423005834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423005834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:05:07Z","timestamp":1777529107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423005834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":33,"alternative-id":["S0223523423005834"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115617","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimycobacterial pyridine carboxamides: From design to in vivo activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115617"}}